METTL3 is also upregulated in breast cancer, where it increases methylation and stability of HBXIP mRNA, which induces cell proliferation and survival of tumour cells via inhibiting the tumour suppressor let-7 g [119]. The gene discussed is METTL3; the disease is neoplasm.